Holen Sie sich die Stockscreener-App
4.27
1.61%
-0.07
Handel nachbörslich:
4.26
-0.010
-0.23%
Finanzdaten der Immuneering Corp-Aktie (IMRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.58%
13.75
|
15.38 | - | 15.48 | 18.56 |
| Operating Income/Loss |
10.58%
-13.75
|
-15.38 | - | -15.48 | -18.56 |
| Income/Loss From Continuing Operations Before Tax |
22.62%
-11.58
|
-14.96 | -14.43 | -15.05 | -18.05 |
| Income/Loss From Continuing Operations After Tax |
22.62%
-11.58
|
-14.96 | -14.43 | -15.05 | -18.05 |
|
Net Income/Loss
|
22.62%
-11.58
|
-14.96 | -14.43 | -15.05 | -18.05 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
82.52%
6.9348
|
39.67 | - | 35.53 | 0.3589 |
| Diluted Average Shares |
82.52%
6.9348
|
39.67 | - | 35.53 | 0.3589 |
| Basic Earnings Per Share |
81.58%
-0.07
|
-0.38 | - | -0.42 | -0.59 |
| Diluted Earnings Per Share |
81.58%
-0.07
|
-0.38 | - | -0.42 | -0.59 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):